Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Purchase of 250,000 ALDX shares, $418.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Aldeyra Therapeutics, Inc. (ALDX) | Purchase | 250,000 | $418.4K |
| Mar 31, 2026 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 1,880,510 | n/a |
| Dec 17, 2025 | Evoke Pharma Inc (EVOK) | Tender of Shares | 27 | n/a |
| May 22, 2025 | Evoke Pharma Inc (EVOK) | Grant/Award | 1,187 | n/a |
| Mar 6, 2025 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/Award | 809,710 | n/a |
| Jan 29, 2025 | Evoke Pharma Inc (EVOK) | Grant/Award | 5,833 | n/a |
| May 24, 2024 | Evoke Pharma Inc (EVOK) | Grant/Award | 14,625 | n/a |
| Mar 13, 2024 | Aldeyra Therapeutics, Inc. (ALDX) | Sale | 97,914 | $320.5K |
| Sep 11, 2023 | Aldeyra Therapeutics, Inc. (ALDX) | Exercise/Conversion | 192,084 | $106.0K |
| May 11, 2023 | Evoke Pharma Inc (EVOK) | Grant/Award | 14,625 | n/a |